Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A gift from nature: the birth of the statins

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Micrograph of Penicillium citrinum Pen-51, the fungus that produces compactin.
Figure 2: A comparison of the structures of four statins and mevalonate.
Figure 3: Akira Yamamoto's homozygous patient with familial hypercholesterolemia who first received compactin in 1978.

Akira Yamamoto


  1. 1

    Endo, A., Kuroda, M. & Tsujita, Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J. Antibiot. (Tokyo) 29, 1346–1348 (1976).

    Article  CAS  Google Scholar 

  2. 2

    Endo, A., Kuroda, M. & Tanzawa, K. Competitive inhibition of 3-hydroxy-3- methylglutaryl coenzyme A reductase by ML-236A and ML 236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 72, 323–326 (1976).

    Article  CAS  PubMed  Google Scholar 

  3. 3

    Endo, A., Tsujita, Y., Kuroda, M. & Tanzawa, K. Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim. Biophys. Acta 575, 266–276 (1979).

    Article  CAS  PubMed  Google Scholar 

  4. 4

    Tsujita, Y., Kuroda, M., Tanzawa, K., Kitano, N. & Endo, A. Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Atherosclerosis 32, 307–313 (1979).

    Article  CAS  PubMed  Google Scholar 

  5. 5

    Endo, A. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33, 1569–1582 (1992).

    PubMed  CAS  Google Scholar 

  6. 6

    Steinberg, D. An interpretative history of the cholesterol controversy. V. The discovery of the statins and the end of the controversy. J. Lipid Res. 47, 1339–1351 (2006).

    Article  CAS  PubMed  Google Scholar 

  7. 7

    Yamamoto, A., Sudo, H. & Endo, A. Therapeutic effects of ML-236B in primary hypercholesterolemia. Atherosclerosis 35, 259–266 (1980).

    Article  CAS  PubMed  Google Scholar 

  8. 8

    Alberts, A.W. et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA 77, 3957–3961 (1980).

    Article  CAS  PubMed  Google Scholar 

  9. 9

    Mabuchi, H. et al. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia. N. Engl. J. Med. 305, 478–482 (1981).

    Article  CAS  PubMed  Google Scholar 

Download references


There are too many friends and colleagues who have contributed to this work over the years to name them individually, but special thanks must go to M. Kuroda for his key role in searching for HMG-CoA reductase inhibitors, to N. Kitano for collaborating in evaluating compactin in hens, dogs and monkeys, and to A. Yamamoto, who first gave compactin to a patient with severe hypercholesterolemia. I am greatly indebted to J. Goldstein and M. Brown, whose friendship and expertise have proved so valuable during my career. And finally, I would like to express my deep gratitude to the Lasker Foundation for the honor of being distinguished with such a prestigious award, which I share with all the members of my laboratories at both Sankyo and Tokyo Noko University.

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Endo, A. A gift from nature: the birth of the statins. Nat Med 14, 1050–1052 (2008).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing